Show
Sort by
-
- Journal Article
- A1
- open access
High efficacy of huCD20-targeted AcTaferon in humanized patient derived xenograft models of aggressive B cell lymphoma
-
- Journal Article
- A1
- open access
Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication
-
- Journal Article
- A1
- open access
Safe eradication of large established tumors using neovasculature-targeted tumor necrosis factor-based therapies
-
Influence of cinaciguat on gastrointestinal motility in apo-sGC mice
-
ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade
-
- PhD Thesis
- open access
Study of molecular and immunological factors that determine the sensitivity to the antitumor effect of Tumor Necrosis Factor
(2008)